David Drutz

CIK 1428764 · Executive Chairman and CMO · last filed 2024-08-20

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$218.9K

Companies

2

Total Filings

38

Lifetime Open-Market Net

$50.0K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ALT Director 83,859 $2.61 $218.9K -$35.8K 21 2024-08-20
Midatech Pharma US Inc. (DARA) Delisted Executive Chairman and CMO 0 $85.7K 17 2015-12-07

Recent Filings · Page 4 of 4

38 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2012-05-30 Midatech Pharma US Inc. (DARA) Delisted Buy (P) +25,000 $22.5K EDGAR
2012-05-17 Midatech Pharma US Inc. (DARA) Delisted Grant (A) $0 EDGAR
2011-12-29 Midatech Pharma US Inc. (DARA) Delisted Grant (A) $0 EDGAR
2011-04-04 Midatech Pharma US Inc. (DARA) Delisted Grant (A) $0 EDGAR
2010-03-25 Midatech Pharma US Inc. (DARA) Delisted Grant (A) $0 EDGAR
2010-01-12 Midatech Pharma US Inc. (DARA) Delisted Grant (A) +10,000 $0 EDGAR
2009-03-06 Midatech Pharma US Inc. (DARA) Delisted Grant (A) +4,167 $0 EDGAR
2008-04-30 Midatech Pharma US Inc. (DARA) Delisted Grant (A) +35,000 $0 EDGAR
Showing 3138 of 38
Page 4 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.